Cargando…

Italian Association of Hospital Cardiologists practical guidance for sodium–glucose cotransporter 2 inhibitors use in patients with heart failure

Sodium–glucose cotransporter 2 inhibitors (SGLT2-is) have recently been included among the first-line drugs for the treatment of heart failure with reduced ejection fraction. International guidelines recommend SGLT2-i use in association with neuro-hormonal modulators (renin–angiotensin blockers, bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Fusco, Stefania Angela, Spinelli, Antonella, Aquilani, Stefano, Borrelli, Nunzia, Iannopollo, Gianmarco, Gulizia, Michele Massimo, Gabrielli, Domenico, Oliva, Fabrizio, Colivicchi, Furio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194818/ https://www.ncbi.nlm.nih.gov/pubmed/37213801 http://dx.doi.org/10.1093/eurheartjsupp/suad107

Ejemplares similares

Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)
por: Mocini, David, et al.
Publicado: (2021)

Spotlight on Italian Association of Hospital Cardiologists (ANMCO) activity in the 2–year period 2021–2023
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

Impact of Working from Home on Cardiovascular Health: An Emerging Issue with the COVID-19 Pandemic
por: Di Fusco, Stefania Angela, et al.
Publicado: (2021)

Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey
por: Camilli, Massimiliano, et al.
Publicado: (2023)

Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Society of Emergency Medicine (SIMEU) and Italian Society of Interventional Cardiology (SICI-GISE)
por: De Luca, Leonardo, et al.
Publicado: (2017)

How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post‐MI Study
por: De Luca, Leonardo, et al.
Publicado: (2019)

ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation
por: Di Fusco, Stefania Angela, et al.
Publicado: (2022)

ANMCO position paper on vericiguat use in heart failure: from evidence to place in therapy
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures
por: Caporale, Roberto, et al.
Publicado: (2017)

Type of hospitalisations and in-hospital outcomes in the Italian coronary care unit network at the time of COVID-19 pandemic: the BLITZ-COVID19 Registry
por: Gulizia, Michele Massimo, et al.
Publicado: (2022)

Incidence, Characteristics, and Management of Patients with Recurrent Myocardial Infarctions: Insights from the EYESHOT POST-MI
por: De Luca, Leonardo, et al.
Publicado: (2022)

Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study
por: De Luca, Leonardo, et al.
Publicado: (2022)

Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
por: Canale, Maria Laura, et al.
Publicado: (2021)

Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey
por: Canale, Maria Laura, et al.
Publicado: (2022)

ANMCO position paper: 2022 focused update of appropriate use criteria for multimodality imaging: aortic valve disease
por: Nardi, Federico, et al.
Publicado: (2022)

ANMCO POSITION PAPER: Use of sacubitril/valsartan in hospitalized patients with acute heart failure
por: Di Tano, Giuseppe, et al.
Publicado: (2021)

Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience
por: Zwart, K., et al.
Publicado: (2021)

COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
por: Abrignani, Maurizio G., et al.
Publicado: (2022)

The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure
por: Colivicchi, Furio, et al.
Publicado: (2020)

Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
por: Bisceglia, Irma, et al.
Publicado: (2022)

Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
por: Bisceglia, Irma, et al.
Publicado: (2022)

Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story
por: Bisceglia, Irma, et al.
Publicado: (2023)

ANMCO-SIMEU consensus document: appropriate management of atrial fibrillation in the emergency department
por: Caldarola, Pasquale, et al.
Publicado: (2023)

Clinical Utility of Three-Dimensional Echocardiography in the Evaluation of Mitral Valve Disease: Tips and Tricks
por: Pino, Paolo G., et al.
Publicado: (2023)

ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes
por: Gronda, Edoardo, et al.
Publicado: (2021)

Women at heart: Introducing gender cardio-oncology
por: Canale, Maria Laura, et al.
Publicado: (2022)

The role of the pregnancy heart team in clinical practice
por: Lucà, Fabiana, et al.
Publicado: (2023)

Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries
por: Colivicchi, Furio, et al.
Publicado: (2020)

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death
por: Casolo, Giancarlo, et al.
Publicado: (2023)

ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndrome
por: De Luca, Leonardo, et al.
Publicado: (2023)

Reply to Kielb et al. Untapped Potential for Female Patients? Comment on “Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176”
por: Lucà, Fabiana, et al.
Publicado: (2022)

National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020
por: Adhikari, Rishav, et al.
Publicado: (2022)

Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Pediatric Cardiology (SICP), and Italian Society of Gynaecologists and Obstetrics (SIGO): pregnancy and congenital heart diseases
por: Bianca, Innocenzo, et al.
Publicado: (2017)

ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)
por: Bisceglia, Irma, et al.
Publicado: (2021)

Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes
por: Parrini, Iris, et al.
Publicado: (2022)

Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023)

ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosis
por: Casolo, Giancarlo, et al.
Publicado: (2021)

Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries
por: Olimpieri, P.P., et al.
Publicado: (2020)

ANMCO position paper ‘Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation’
por: Mocini, David, et al.
Publicado: (2022)

Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
por: Gronda, Edoardo G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tt4i2gefq4jf6l0icpmp3liv9c